On November 28, Gelunhui announced that according to the notice issued by the National Medical Insurance Bureau and the Ministry of Human Resources and Social Security on the "National Basic Medical Insurance, Work Injury Insurance, and Maternity Insurance Drug List (2024)", the company's pharmaceutical Wenjing Tang granules and the pharmaceutical injection cefuroxime sodium of its wholly-owned subsidiary Zhejiang China Resources Jiuzhong Pharmaceutical Co., Ltd. were first included in the "National Basic Medical Insurance, Work Injury Insurance, and Maternity Insurance Drug List (2024)" through negotiation for the first time.
华润三九(000999.SZ)：公司及子公司产品通过谈判首次纳入国家医保目录
China Resources Sanjiu Medical & Pharmaceutical (000999.SZ): The products of the company and its subsidiaries are included in the national medical insurance catalog for the first time through negotiations.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Investment Course
Choose stocks based on financial reports
Quickly master financial season learning guidelines
When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
How to view Tesla's performance in January 2025? Pay attention to these four key points.
It's earnings season for US stocks again. The performance of giant companies not only affects their own stock prices but also influences the overall trend of th
In 【2024.11】, surged more than 0.04 million times, achieving the title of stock god Buffett! How do you view Berkshire's performance?
When it comes to legendary figures in the investment world, the name of Warren Buffett, the helm of Berkshire Hathaway, is definitely unavoidable. $Berkshire Ha